Sponsor:
Joseph M. Still Research Foundation, Inc.
Code:
NCT05477225
Conditions
Hidradenitis Suppurativa
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
NovoSorb® BTM
Human Cadaveric Allograft
Brief summary:
Conditions
Hidradenitis Suppurativa
Study ID
NCT05477225
Start date
Oct 1, 2022
Status verified date
Sep, 2023
Completion date
Jul 30, 2025
Anticipated
Primary completion date
Jul 30, 2024
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
10 participants
Anticipated
Allocation
Randomized
Intervention Model
Single group
Primary purpose
Treatment
Arms
experimental: NovoSorb® BTM
active comparator: Human Cadaver Allograft
Interventions
NovoSorb® BTM
Human Cadaveric Allograft
Primary outcome measure
Central contacts
Locations
Joseph M. Still Research Foundation
Recruiting
Augusta, Georgia, United States, 30909
Contacts
Principal Investigator:
Bounthavy Homsombath, M.D
Sponsor
Joseph M. Still Research Foundation, Inc.
Last update posted
Sep 28, 2023
Last verified
Sep, 2023
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-05. This information was provided to ClinicalTrials.gov by Joseph M. Still Research Foundation, Inc. on 2023-09-28.